-
Mea Mata |Active Pharmaceutical Ingredient Intermediates |Ma'i suka |(R)-3-(Boc-Amino)piperidine |CAS:309956-78-3 |C10H20N2O2
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Active Pharmaceutical Ingredient Intermediates |Ma'i suka |(R)-3-(Boc-Amino)piperidine |CAS:309956-78-3 |C10H20N2O2
-
Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Amino acid series |D-Lysine |CAS:923-27-3 |C6H14N2O2
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Amino acid series |D-Lysine |CAS:923-27-3 |C6H14N2O2
-
Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS Nu.:2212-75-1 |C34H42N2O6
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |N-alpha-Cbz-L-lysine |CAS Nu.:2212-75-1 |C34H42N2O6
-
Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |N-alpha-Cbz-L-lysine |Numera CAS:204777-78-6
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |N-alpha-Cbz-L-lysine |Numera CAS:204777-78-6 |C34H42N2O6
-
Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |ZD-LYS-OH |CAS Nu.:70671-54-4 |C14H20N2O4
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Immunology |Fa'atupu peptide |Natural Amino Acid |ZD-LYS-OH |CAS Nu.:70671-54-4 |C14H20N2O4
-
Reagents Intermediates Pharmaceutical |Mea mata |Oxirane, 2-(7Z,10Z) -7,10-hexadecadyen-1-yl- |Numera CAS:1883429-78-4
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |Oxirane, 2-(7Z,10Z) -7,10-hexadecadyen-1-yl- |CAS Nu.:1883429-78-4 |C18H32O
-
Vailaau Fa'atekonolosi |Mea mata |BOC-(S)-HABA |Numera CAS:207305-60-0 |C9H17NO5
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |BOC-(S)-HABA |Numera CAS:207305-60-0 |C9H17NO5
-
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |Antibiotic |Tetracycline Intermediates|Sancycline hydrochloride |CAS:6625-20-3
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |Antibiotic |Tetracycline Intermediates|Sancycline hydrochloride |CAS:6625-20-3 |C21H23ClN2O7
-
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |Antibiotic |Tetracycline Intermediates|Minocycline hydrochloride |CAS:13614-98-7
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Reagents Intermediates Pharmaceutical |Mea mata |Antibiotic |Tetracycline Intermediates|Minocycline hydrochloride |CAS:13614-98-7 |C23H28ClN3O7
-
Biopharmaceutical |Fa'ama'i cardiovascular |L-Octahydroindole-2- carboxylicacidbenzylester 4- methylbenzenesulfonate |CAS:94062-52-9 |C16H21NO2.C7H8O3S
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Fa'ama'i cardiovascular |Toto Maualuga |L-Octahydroindole-2- carboxylicacidbenzylester 4- methylbenzenesulfonate |CAS:94062-52-9 |C16H21NO2.C7H8O3S
-
Biopharmaceutical |Fa'ama'i cardiovascular |2-Chloro-L-phenylalanine |CAS:103616-89-3
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Fa'ama'i cardiovascular |Toto Maualuga |2-Chloro-L-phenylalanine |CAS:103616-89-3 |C9H10ClNO2
-
Mea Mata |Vailaau Fa'atekonolosi |Cardiovascular |Fa'ama'i |L-Norvaline ethyl ester hydrochloride |CAS:40918-51-2 |C7H16ClNO2
Fa'apolofesa gaosiga ma tu'uina atu biopharmaceutical |Mea Mata |Reagents Intermediates Pharmaceutical |Fa'ama'i cardiovascular |Toto Maualuga |L-Norvaline ethyl ester hydrochloride |CAS:40918-51-2 |C7H16ClNO2